Suwatthanarak, Tharathorn
Tanjak, Pariyada
Suwatthanarak, Thanawat
Acharayothin, Onchira
Thanormjit, Kullanist
Chaiboonchoe, Amphun
Tawantanakorn, Thikhamporn
Phalanusitthepha, Chainarong
Trakarnsanga, Atthaphorn
Methasate, Asada
Pithukpakorn, Manop
Okamoto, Ryuichi
Chinswangwatanakul, Vitoon
Funding for this research was provided by:
Foundation for Cancer Care, Siriraj Hospital, Thailand (R016241047, R016241047, R016241047, R016241047, R016241047)
Health Systems Research Institute (HSRI) of Thailand (63-117, 63-117, 63-117, 63-117, 63-117)
Article History
Received: 6 July 2023
Accepted: 1 November 2023
First Online: 7 December 2023
Declarations
:
: The institutional review board (IRB) of Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand approved the study protocol with reference number Si 105/2021. The study was conducted following good research practices according to the International Guideline for Human Research Protection and the Declaration of Helsinki. All informed consents were obtained from the patients after we provided detailed information about the research aims, policy, potential risks and benefits, and privacy concerns.
: Not applicable.
: The authors declare no competing interests.